リケラボ論文検索は、全国の大学リポジトリにある学位論文・教授論文を一括検索できる論文検索サービスです。

リケラボ 全国の大学リポジトリにある学位論文・教授論文を一括検索するならリケラボ論文検索大学・研究所にある論文を検索できる

リケラボ 全国の大学リポジトリにある学位論文・教授論文を一括検索するならリケラボ論文検索大学・研究所にある論文を検索できる

大学・研究所にある論文を検索できる 「Sequential changes in patient enablement instrument during a smoking cessation program and its effect on smoking abstinence (Original)」の論文概要。リケラボ論文検索は、全国の大学リポジトリにある学位論文・教授論文を一括検索できる論文検索サービスです。
リケラボ

コピーが完了しました

URLをコピーしました

論文の公開元へ論文の公開元へ
書き出し

Sequential changes in patient enablement instrument during a smoking cessation program and its effect on smoking abstinence (Original)

村山, 慎一 杉山, 佳史 松島, 雅人 東京慈恵会医科大学

2020.12.10

概要

Objectives : This study aimed to described the sequential changes in the Patient Enablement In- strument (PEI) scores during a smoking cessation program and to clarify the effect of PEI scores on short- and long-term smoking abstinence.

Methods : This prospective cohort study included 110 patients from one hospital and nine clin- ics from November 1, 2015, to February 28, 2018. The main predictor is PEI scores at 1st consulta- tion (PEI1) and final evaluation (last-PEI). The primary outcome is smoking abstinence at 4 and 24 weeks.

Results : Among 110 patients (38 females, 72 males ; mean age ± standard devia- tion : 53.2±16.6 years), 75 (75/110 ; 68.2%) and 49 (49/97 ; 50.5%) individuals achieved 4 and 24 weeks' abstinence. Those who achieved 4 weeks' abstinence had higher PEI1 scores than those who did not (5.52±3.06 vs. 4.00±2.97). Those who achieved 24 weeks’ abstinence had higher PEI1 and last-PEI scores than those who did not (PEI1 : 5.85±3.14 vs. 4.12±2.94 ; last-PEI : 7.45±3.73 vs. 5.19±3.23). PEI scores indicated the statistically significant increase during the program. After ad- justing for covariates by logistic regression analyses, PEI1 and last-PEI scores had a significant effect on 24 weeks' abstinence.

Conclusions : Patient enablement increased over time during a standardized smoking cessation program, and PEI1 and last-PEI scores were significant predictors for 24 weeks of smoking absti- nence.

論文の公開元へ

関連論文

関連論文をもっと見る

参考文献

1. 2008-2013 Action plan for the global strategy for the preven- tion and control of noncommunicable diseases. WHO Press, 2008. https://www.who.int/nmh/publications/9789241597418/en/ [accessed 2020-2-22].

2. Glantz S, Gonzalez M. Effective tobacco control is key to rapid progress in reduction of non-communicable diseases. Lancet. 2012 ; 379 : 1269-71.

3. Ikeda N, Inoue M, Iso H, Ikeda S, Satoh T, Noda M, et al. Adult mortality attributable to preventable risk factors for non-communicable diseases and injuries in Japan : a compara- tive risk assessment. PLoS Med. 2012 ; 9 : e1001160.

4. Kasza KA, Hyland AJ, Borland R, McNeill AD, Bansal-Travers M, David Hammond BF, et al. Effectiveness of stop-smoking medications : findings from the International Tobacco Control (ITC) Four Country Survey. Addiction. 2013 ; 108 : 193-202.

5. Cahill K, Stevens S, Perera R, Lancaster T. Pharmacological interventions for smoking cessation : an overview and net- work meta-analysis. Vol. 2013, Cochrane Database Syst Rev. 2013 : CD009329.

6. Soria R, Legido A, Escolano C, Yeste AL, Montoya J. A ran- domised controlled trial of motivational interviewing for smoking cessation. Br J Gen Pract. 2006 ; 56(531) : 768-74.

7. JCS Joint Working Group ; Japanese Society for Oral Health ; Japanese Society of Oral and Maxillofacial Sur- geons ; Japanese Society of Public Health ; Japanese Respi- ratory Society ; Japan Society of Obstetrics and Gynecology et al. Guidelines for Smoking Cessation (JCS 2010) ─ digest version. Circ J. 2012 ; 76 : 1024-43.

8. Gwaltney CJ, Metrik J, Shiffman S. Self-efficacy and smoking cessation : a meta-analysis. Psychol Addict Behav. 2013 ; 23(1) : 1-20.

9. Chie T, Hideo T, Aki I, Syoko A, Mihoko S, Ayumi K et al. Fac- tors associated with 4-weeks quit rate before the end of smoking cessation therapy in Japan. Japanese Journal of To- bacco Control. 2011 ; 6(3) : 34-40.

10. Marino MG, Fusconi E, Magnatta R, Panà A, Maurici M. Epi- demiologic determinants affecting cigarette smoking cessation : A retrospective study in a national health system (SSN) treatment service in Rome (Italy). J Environ Public 28 S. MURAYAMA, et al. Vol. 67, No. 1-4 Health. 2010 ; 2010 : 183206. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2853854/ [accessed 2020-2-22].

11. Howie JG, Heaney DJ, Maxwell M. Measuring quality in gen- eral practice. Pilot study of a needs, process and outcome measure. Occas Pap R Coll Gen Pract. 1997 ; (75) : i-xii, 1-32.

12. Howie JG, Heaney DJ, Maxwell M, Walker JJ, Freeman GK, Rai H. Quality at general practice consultations : cross sec- tional survey. BMJ. 1999 ; 319(7212) : 738-43.

13. Howie JG, Heaney DJ, Maxwell M, Walker JJ. A comparison of a Patient Enablement Instrument (PEI) against two estab- lished satisfaction scales as an outcome measure of primary care consultations. Fam Pract. 1998 ; 15(2) : 165-71.

14. Kurosawa S, Matsushima M, Fujinuma Y, Hayashi D, Noro I, Kanaya T, et al. Two principal components, coping and inde- pendence, comprise patient enablement in Japan : cross sec- tional study in Tohoku area. Tohoku J Exp Med. 2012 ; 227(2) : 97-104.

15. Kawakami N, Takatsuka N, Inaba S. Development of a screen- ing questionnaire for tobacco/nicotine dependence according to ICD-10, DSM-III-R, and DSM-IV. Addict Behav. 1999 ; 24(2) : 155-66.

16. Japanese Society of Circulation, The Japan Lung Cancer Soci- ety, Japan Cancer Association, et al. 6th manual of anti-smok- ing therapy in Japan, 2014. In Japanese. http://www.j-circ.or.jp/ kinen/anti_smoke_std/pdf/anti_smoke_std_rev6.pdf [accessed 2020-2-22].

17. The Health Consequences of Smoking : A Report of the Sur- geon General U.S. Department of Health and Human Services National Library of Medicine 2004 vol : 2012. Office of the Surgeon General (US), Office on Smoking and Health (US) At- lanta (GA) : Centers for Disease Control and Prevention (US) ; 2004. https://www.ncbi.nlm.nih.gov/books/NBK44695/ pdf/Bookshelf_NBK44695.pdf [accessed 2020-2-22].

18. Haughney J, Cotton P, Rosen J, Morrison K, Price D. The use of a modification of the Patient Enablement Instrument in asthma. Prim Care Respir J. 2007 Apr ; 16(2) : 89-92.

19. Fagerström KO. Measuring degree of physical dependence to tobacco smoking with reference to individualization of treat- ment. Addict Behav. 1978 ; 3(3-4) : 235-41.

20. Heatherton TF, Kozlowski LT, Frecker RC, Fagerström KO. The Fagerström Test for Nicotine Dependence : a revision of the Fagerström Tolerance Questionnaire. Br J Addict. 1991 ; 86(9) : 1119-27.

21. Cohen J. Statistical Power Analysis for the Behavioral Scienc- es, second edition. New York : Lawrence Erlbaum Associates, Publishers 1998 : 19-74.

22. StataCorp. 2011. Stata Statistical Software : Release 12. Col- lege Station, TX : StataCorp LP.

23. StataCorp. 2017. Stata Statistical Software : Release 15. Col- lege Station, TX : StataCorp LLC.

24. Peduzzi P, Concato J, Kemper E, Holford TR, Feinstein AR. A simulation study of the number of events per variable in logis- tic regression analysis. J Clin Epidemiol. 1996 ; 49(12) : 1373-9.

25. Mafalda R, Pedro MT, Irene L, Luís S, Jaime CS. The Modified Patient Enablement Instrument : A Portuguese Cross-Cul- tural Adaptation, Validity and Reliability Study. NPJ Prim Care Respir Med. 2017 Jan 12 ; 27 : 16087.

26. Ministry of Health, Labour and Welfare Central Social Insur- ance Medical Council General Meeting : Special Survey on Verification of Results of Reimbursement for Medical Care. A survey report on the success rate of smoking cessation in medical institutions that calculate nicotine dependence man- agement fees (2009 Survey) in Japanese. https://www.mhlw. go.jp/shingi/2010/06/dl/s0602-3i.pdf [accessed 2020-2-22].

27. Hsueh Y. The Hawthorne experiments and the introduction of Jean Piaget in American industrial psychology, 1929-1932. Hist Psychol. 2002 ; 5(2) : 163-89.

28. Hughes JR. Effects of abstinence from tobacco : valid symp- toms and time course. Nicotine Tob Res. 2007 ; 9(3) : 315- 27.

参考文献をもっと見る

全国の大学の
卒論・修論・学位論文
を
一発検索！

この論文の関連論文を見る